Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

OBJECTIVE: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people with multiple sclerosis (PwMS). METHODS: We retrospectively collected data of PwMS with suspected or confirmed COVID‐19. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Sormani, Maria P., De Rossi, Nicola, Schiavetti, Irene, Carmisciano, Luca, Cordioli, Cinzia, Moiola, Lucia, Radaelli, Marta, Immovilli, Paolo, Capobianco, Marco, Trojano, Maria, Zaratin, Paola, Tedeschi, Gioacchino, Comi, Giancarlo, Battaglia, Mario A., Patti, Francesco, Salvetti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013440/
https://www.ncbi.nlm.nih.gov/pubmed/33480077
http://dx.doi.org/10.1002/ana.26028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013440/
https://www.ncbi.nlm.nih.gov/pubmed/33480077
http://dx.doi.org/10.1002/ana.26028

Ejemplares similares